Pall T. Onundarson Urges You to Watch It: Emerging Anticoagulants and Reversal Agents What’s Next in the Pipeline?
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, recently shared on LinkedIn, reposting from Anticoagulation Forum:
”Something to think about. Great savings if you want them.”
Anticoagulation Forum posted on Emerging Anticoagulants on LinkedIn:
‘Missed it live? Now’s your chance to catch up — or rewatch! The recording of our recent webinar, Emerging Anticoagulants and Reversal Agents: What’s Next in the Pipeline?, is now available! Watch it here.
As the anticoagulation field continues to evolve, this session delivers expert insights into investigational agents and reversal strategies that may soon impact clinical practice. If you manage complex patients or influence clinical policy, this is one to watch.
Webinar highlights:
- Latest clinical trial data
- Future applications in stroke prevention, dialysis, oncology, and device-related thrombosis
- Practical considerations for frontline care and system-level planning
We are grateful to our speakers and panelists for a fantastic discussion:
Geoffrey Barnes, MD, MSc
Gabe Fontaine PharmD, MBA, BCCCP, BCPS, FNCS, FCCM
Jean Connors, MD
Arthur Allen, PharmD, CACP (Moderator)
Jori May, MD (Moderator)
Free for AC Forum members — membership is quick and free to join. Explore this and hundreds of additional resources to enhance your practice.”
Join AC Forum.
Stay tuned to not miss out on all webinars in the field of coagulation with Hemostasis Today.
-
Sep 18, 2025, 06:50Fetal Hereditary TTP Featured in NEJM – Senior Author Nishant Rajendra Tiwari
-
Sep 17, 2025, 10:54Mitapivat Boosts ATP in Red Cells: Dr. William Aird on New Hope for Hemolytic Disorder
-
Sep 17, 2025, 08:16Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
-
Sep 17, 2025, 07:00Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
-
Sep 16, 2025, 11:17Glenn Pierce: WHO Issues a Biannual Essential Medicines List
-
Sep 18, 2025, 07:00Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
-
Sep 18, 2025, 02:25Flora Peyvandi Highlights 'Inflammatory Memory of Stem Cells' – New Insights for Hematologic Diseases
-
Sep 17, 2025, 16:32Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
-
Sep 17, 2025, 16:28Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
-
Sep 17, 2025, 16:19Todd Villines: Coronary Artery Disease - A BIG Movement to Change
-
Sep 16, 2025, 14:59A New Era in Antiplatelet Therapy for CABG?
-
Sep 16, 2025, 07:44Artificial Blood Breakthrough in Japan: Long Shelf Life, No Type Matching, and a Purple Future
-
Sep 16, 2025, 02:44Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 18, 2025, 06:34'A New Era in Mechanical Thrombectomy?' – Sripal Bangalore Highlights SYMPHONY-PE IDE Study
-
Sep 17, 2025, 10:49Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
-
Sep 17, 2025, 10:22Abdul Mannan: Turning Medical Podcasts into Active Learning with Structured Tools
-
Sep 17, 2025, 09:43Global Blood Supply Under Threat: David McIntosh Calls for Action to Support Transfusion Services
-
Sep 17, 2025, 09:08Coronary Arteries, Pericardial Cavity, and the Hidden Danger of Cardiac Tamponade During PCI-By Ahmed Ata